GGrantIndex
Sort

261,768 grants matching gene therapy

COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2

$4,088,041
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

CSHL CANCER CENTER SUPPORT GRANT

$4,086,019
Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2007 · CA

Molecular Genetics of Vascular Disease

$4,084,492
Elizabeth G Nabel · Human Genome Research · Z01 · FY2007 · HG

VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHES

$4,083,278
Johns Hopkins University · P50 · FY2003 · HL

Cancer Center Support Grant (CCSG)

$4,081,820
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2021 · CA

Cancer Center Support Grant (CCSG)

$4,081,820
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2022 · CA

Cancer Center Support Grant (CCSG)

$4,081,820
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2020 · CA

Cancer Center Support Grant (CCSG)

$4,081,820
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2023 · CA

Cancer Center Support Grant (CCSG)

$4,081,820
Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2024 · CA

Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders

$4,077,456
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

CSHL CANCER CENTER SUPPORT GRANT

$4,077,038
Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2013 · CA

Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies

$4,075,119
Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma

$4,070,979
Thomas A Waldmann · Clinical Sciences · Z01 · FY2007 · CA

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT

$4,069,353
University Of Southern California · P30 · FY2000 · CA

Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection

$4,068,789
Keith R Jerome · Fred Hutchinson Cancer Research Center · U19 · FY2014 · AI

Regulation of retinal development

$4,068,373
Anand Swaroop · National Eye Institute · ZIA · FY2014 · EY

Molecular Determinants of Pulmonary Arterial Hypertension

$4,067,813
Paul M Hassoun · Johns Hopkins University · P50 · FY2007 · HL

Exploring pathophysiologic mechanisms to assess risk and optimize treatment outcomes in patients with mitral regurgitation

$4,066,506
Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · HL

University of Pittsburgh MACS/WIHS CCS

$4,064,074
Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · HL

Adoptive Cell Transfer Immunotherapy of Cancer

$4,057,426
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Gene therapy of cancer

$4,057,426
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

CCR Collaborative Bioinformatics Resource

$4,057,258
Mariam Malik · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Molecular Determinants of Pulmonary Arterial Hypertension

$4,056,519
Paul M Hassoun · Johns Hopkins University · P50 · FY2008 · HL

JACKSON HEART STUDY

$4,055,231
Herman Alfred Taylor · Jackson State University · N01 · FY2009 · HL

University of Pittsburgh MACS/WIHS CCS

$4,055,102
Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · HL